BIOINDUSTRY · R&D SERVICES

Formulation and stabilisation

A live strain, an enzyme or an extract that work in solution are not yet a product. Formulation is the work that makes them handleable, dosable and stable for as long as your market requires — and the stability studies are what proves it rather than promising it.

Talk to us about your product
WHERE IT STARTS

Three problems formulation solves

A formulation almost always starts from one of these three. Which one it is decides where the first stage puts its effort.

The active does not survive

A microorganism losing viability, an enzyme losing activity, a molecule degrading. The work is on the matrix, the protectants and the drying process together, not on one of the three.

The product cannot be handled

A powder that will not flow, a format that will not dose, a material that takes up moisture. These are measurable physical properties, and they get measured before anything is changed.

The shelf life is not demonstrated

The product holds, but nobody can prove it to a customer or an authority. Standard, accelerated and stress studies, with the time points defined at the start.

How a project runs

Three stages, each ending in a decision rather than a report. How long each takes depends on the active and the final format — we size it after the first conversation, not before.

Stage one

Formulation screening

It starts from the active and from the format it has to end up in. One or two formulation options compared on a small quantity of finished product, with protectants and excipients chosen against the degradation mechanism you are actually fighting, not out of habit.

Stage two

Drying optimisation

Spray drying parameters or the lyophilisation cycle, with design of experiments where there are more than two variables. This is where the cost of the product is decided: cycle time and recovery weigh more than the recipe.

Stage three

Stability and industrialisation

A stability study with scheduled time points at several temperatures, scale-up of the process, and the conditions written down well enough to move into production.

What we measure

A formulation is easy to propose and hard to prove over time. These are the endpoints we report.

  • Residual activity or viable count — right after the process and then over time, with the method declared
  • Stability curve — at several temperatures and with scheduled time points, not a single end point
  • Process yield — how much product reaches the end of the cycle, which is half the cost
  • Moisture and water activity — the two parameters behind most degradation
  • Format properties — flowability, reconstitution, particle size, hygroscopic behaviour
  • Stress testing — deliberately severe conditions, to know where the product fails before it fails at a customer
  • Compatibility in formula — how the active behaves alongside the other ingredients of the finished product
  • Batch-to-batch reproducibility — the same formulation repeated, with the spread declared

The laboratory behind it

Equipment

DryingIn-house pilot spray dryer; lyophilisation cycles developed by us and run at the scale the project requires
StabilityStudies at controlled temperatures, in standard, accelerated and stress conditions
AnalyticsAgilent and Shimadzu instrumentation: HPLC, UPLC, spectrophotometers and titrators; viable counts and activity assays according to the active

What you take away

FormulationThe formulation itself, with excipients, ratios and process conditions
DossierStability data, conditions tested and results, in the form your technical file needs
Pilot batchProduction at scale when the project reaches that point

Start with the active

Tell us what has to be stabilised, in what format and for how long it has to hold. We will tell you what the first screening would look like.

Talk to us about your product

Tell us about your project

Write to us here: the division team will get back to you.